Biovaxys Technology Corp Stock Today
| BVAXF Stock | USD 0.04 0 8.72% |
Performance0 of 100
| Odds Of DistressOver 88
|
Biovaxys Technology is trading at 0.0398 as of the 11th of December 2024. This is a 8.72% down since the beginning of the trading day. The stock's lowest day price was 0.0365. Biovaxys Technology has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 11th of November 2024 and ending today, the 11th of December 2024. Click here to learn more.
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320 and agreement with Bioanalytical Systems, Inc. The company has 106.72 M outstanding shares. More on Biovaxys Technology Corp
Moving against Biovaxys OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biovaxys OTC Stock Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Biovaxys Technology Corp [BVAXF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biovaxys Technology's market, we take the total number of its shares issued and multiply it by Biovaxys Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biovaxys Technology Corp classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 106.72 M outstanding shares.
Biovaxys Technology Corp has accumulated about 39.05 K in cash with (5.29 M) of positive cash flow from operations.
Check Biovaxys Technology Probability Of Bankruptcy
Ownership AllocationBiovaxys Technology holds a total of 106.72 Million outstanding shares. Biovaxys Technology Corp shows 18.94 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biovaxys Ownership Details
Biovaxys Technology Corp Risk Profiles
Biovaxys Stock Against Markets
Picking the right benchmark for Biovaxys Technology otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biovaxys Technology otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biovaxys Technology is critical whether you are bullish or bearish towards Biovaxys Technology Corp at a given time. Please also check how Biovaxys Technology's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biovaxys Technology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Other Information on Investing in Biovaxys OTC Stock
Biovaxys Technology financial ratios help investors to determine whether Biovaxys OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovaxys with respect to the benefits of owning Biovaxys Technology security.